رجوع
نطاق اليوم
KWD 17.95
KWD 20.37
نطاق 52 أسبوعًا
KWD 15.08
KWD 21.08
حجم التداول
50
متوسط 50 يوم / 200 يوم
KWD 19.28
/
KWD 17.74
الإغلاق السابق
KWD 20.37
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.4 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 8.4 | 3.7 |
| Net Margin % | 10.6 | 3.8 |
| Rev Growth 5Y % | 18.2 | 10.0 |
| D/E | 0.1 | 0.2 |
النقاط الرئيسية
Revenue grew 18.19% annually over 5 years — strong growth
Earnings declined -19.43% over the past year
Debt/Equity of 0.07 — conservative balance sheet
Generating 31.97B in free cash flow
P/E of 0.42 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.59%
النمو
Revenue Growth (5Y)
18.19%
Revenue (1Y)11.60%
Earnings (1Y)-19.43%
FCF Growth (3Y)123.05%
الجودة
Return on Equity
8.44%
ROIC13.96%
Net Margin10.61%
Op. Margin25.06%
الأمان
Debt / Equity
0.07
Current Ratio3.71
Interest Coverage140.56
التقييم
P/E Ratio
0.42
P/B Ratio0.04
EV/EBITDA-1.25
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.60% | Revenue Growth (3Y) | 15.42% |
| Earnings Growth (1Y) | -19.43% | Earnings Growth (3Y) | -1.42% |
| Revenue Growth (5Y) | 18.19% | Earnings Growth (5Y) | 6.28% |
| Profitability | |||
| Revenue (TTM) | 120.03B | Net Income (TTM) | 12.74B |
| ROE | 8.44% | ROA | 6.59% |
| Gross Margin | 67.68% | Operating Margin | 25.06% |
| Net Margin | 10.61% | Free Cash Flow (TTM) | 31.97B |
| ROIC | 13.96% | FCF Growth (3Y) | 123.05% |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 3.71 |
| Interest Coverage | 140.56 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 0.42 | P/B Ratio | 0.04 |
| P/S Ratio | 0.05 | PEG Ratio | -2.56 |
| EV/EBITDA | -1.25 | Dividend Yield | 0.01% |
| Market Cap | 5.40B | Enterprise Value | -37.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 120.03B | 107.55B | 90.10B | 77.75B | 61.51B |
| Net Income | 12.74B | 15.81B | 13.11B | 10.86B | 9.98B |
| EPS (Diluted) | 46.92 | 58.20 | 48.25 | 40.00 | 38.07 |
| Gross Profit | 81.24B | 69.05B | 58.83B | 51.08B | 41.47B |
| Operating Income | 30.08B | 22.14B | 18.03B | 15.24B | 12.80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 193.19B | 191.61B | 172.64B | 155.13B | 115.43B |
| Total Liabilities | 41.84B | 39.66B | 38.35B | 34.00B | 22.49B |
| Shareholders' Equity | 150.56B | 151.21B | 132.31B | 119.46B | 92.91B |
| Total Debt | 11.10B | 6.70B | 14.25B | 12.18B | 8.04B |
| Cash & Equivalents | 54.20B | 35.66B | 34.88B | 32.32B | 21.36B |
| Current Assets | 103.36B | 94.70B | 90.26B | 79.61B | 61.13B |
| Current Liabilities | 27.86B | 29.49B | 26.32B | 20.76B | 14.67B |
درجات الاستراتيجيات
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026